PlasmaTech to buy Abeona

PlasmaTech Biopharmaceuticals Inc. (Nasdaq: PTBI) will acquire Abeona Therapeutics for approximately 3.98 million common shares. The stock price jumped $3.10 to $9.07


Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.